Skip to main content

EagleClaw Capital Managment, LLC

Position in LLY — ELI LILLY & Co

CIK 1607636 BOSTON, MA

Position in LLY

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$2,125,390
+$472,564 QoQ
Shares Held
1,772
-1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#2,441
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. LLY ranks #7 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 LLY
ELI LILLY & Co
This page
1,772 $2,125,390

All Filings in LLY

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,125,390 1,772
2026-03-31 $1,652,826 1,797
2025-12-31 $1,902,183 1,770
2025-09-30 $1,388,660 1,820
2025-06-30 $1,336,893 1,715
2025-03-31 $1,410,654 1,708
2024-12-31 $1,326,296 1,718
2024-09-30 $1,522,044 1,718
2024-06-30 $1,561,780 1,725
2024-03-31 $1,341,981 1,725
2023-12-31 $1,040,512 1,785
2023-09-30 $958,777 1,785
2023-06-30 $837,129 1,785
2023-03-31 $621,590 1,810
2022-12-31 $594,490 1,625
2022-09-30 $210,177 650
2022-06-30 $210,749 650
2022-03-31 $200,459 700
2021-12-31 $207,165 750